{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:11Z","timestamp":1788873191066,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660130"],"award-info":[{"award-number":["81660130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province, China","doi-asserted-by":"crossref","award":["18JR3RA045"],"award-info":[{"award-number":["18JR3RA045"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangzhou, China","award":["202102010222"],"award-info":[{"award-number":["202102010222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We measured the serum levels of ANGPTL3 in PNS patients (<jats:italic>n<\/jats:italic>=196). Furthermore, the degree of proteinuria and lipid metabolism were examined in <jats:italic>angptl3<\/jats:italic>-overexpressing transgenic (<jats:italic>angptl3<\/jats:italic>-tg) mice at different ages. Moreover, in this study, we used the clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR\/Cas9) system to create <jats:italic>angptl3<\/jats:italic>-knockout (<jats:italic>angptl3<\/jats:italic>-\/-) mice to investigate lipopolysaccharide (LPS)-induced nephrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with that in the healthy group, the serum level of ANGPTL3 in the PNS group was significantly increased (32 (26.35-39.66) ng\/ml vs. 70.44 (63.95-76.51) ng\/ml, Z =-4.81, <jats:italic>P<\/jats:italic> &lt; 0.001). There were significant correlations between the serum level of ANGPTL3 and the levels of cholesterol (<jats:italic>r<\/jats:italic>=0.34, <jats:italic>P<\/jats:italic> &lt; 0.001), triglycerides (<jats:italic>r<\/jats:italic>= 0.25, <jats:italic>P<\/jats:italic> = 0.001) and low-density lipoprotein (<jats:italic>r<\/jats:italic>= 0.50, <jats:italic>P<\/jats:italic> &lt; 0.001) in PNS patients. With increasing age, <jats:italic>angptl3<\/jats:italic>-tg mice exhibited increasingly severe hypertriglyceridemia and proteinuria. The pathological features of <jats:italic>angptl3<\/jats:italic>-tg mice included rich lipid droplet deposition in hepatocytes and diffuse podocyte effacement. Compared to wild-type mice, <jats:italic>angptl3<\/jats:italic>-\/- mice showed significantly lower degrees of lipid dysfunction and proteinuria after stimulation with LPS. The effects of ANGPTL3 on nephrotic dyslipidemia were confirmed in cultured hepatocytes subjected to <jats:italic>angptl3<\/jats:italic> knockdown or overexpression. Finally, significant alterations in lipoprotein lipase (LPL) levels were observed in liver tissues from Angptl3-\/- and wild-type mice stimulated with LPS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ANGPTL3 could be involved in the development of dyslipidemia, as well as proteinuria, during PNS pathogenesis. Inhibition of LPL expression may the mechanism by which ANGPTL3 induces hyperlipidemia in PNS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-022-01632-y","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T15:06:27Z","timestamp":1649603187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome"],"prefix":"10.1186","volume":"21","author":[{"given":"Fu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,10]]},"reference":[{"issue":"2","key":"1632_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.krcp.2012.04.323","volume":"31","author":"WY Ding","year":"2012","unstructured":"Ding WY, Saleem MA. Current concepts of the podocyte in nephrotic syndrome. Kidney Res Clin Pract. 2012;31(2):87\u201393.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"1632_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. KIDNEY INT. 2016;90(1):41\u201352.","journal-title":"KIDNEY INT"},{"issue":"2","key":"1632_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, et al. Angptl3 regulates lipid metabolism in mice. NAT GENET. 2002;30(2):151\u20137.","journal-title":"NAT GENET"},{"issue":"1","key":"1632_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2010.07.027","volume":"399","author":"X Gao","year":"2010","unstructured":"Gao X, Xu H, Liu H, Rao J, Li Y, Zha X. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro. BIOCHEM BIOPH RES CO. 2010;399(1):31\u20136.","journal-title":"BIOCHEM BIOPH RES CO"},{"issue":"1","key":"1632_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12882-019-1383-1","volume":"20","author":"R Dai","year":"2019","unstructured":"Dai R, Liu H, Han X, Liu J, Zhai Y, Rao J, et al. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss. BMC NEPHROL. 2019;20(1):185.","journal-title":"BMC NEPHROL"},{"issue":"12","key":"1632_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrendo.2017.119","volume":"13","author":"S Kersten","year":"2017","unstructured":"Kersten S. Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol. 2017;13(12):731\u20139.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"1632_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1194\/jlr.P066183","volume":"57","author":"I Minicocci","year":"2016","unstructured":"Minicocci I, Tikka A, Poggiogalle E, Metso J, Montali A, Ceci F, et al. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. J LIPID RES. 2016;57(6):1097\u2013107.","journal-title":"J LIPID RES"},{"issue":"19","key":"1632_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1177\/2047487319884378","volume":"27","author":"M Ruscica","year":"2020","unstructured":"Ruscica M, Macchi C, Fogacci F, Ferri N, Grandi E, Rizzoli E, et al. Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study. EUR J PREV CARDIOL. 2020;27(19):2251\u20134.","journal-title":"EUR J PREV CARDIOL"},{"issue":"9384","key":"1632_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet (London England). 2003;362(9384):629\u201339.","journal-title":"Lancet (London England)"},{"issue":"1","key":"1632_CR10","first-page":"36","volume":"17","author":"V Mahalingasivam","year":"2018","unstructured":"Mahalingasivam V, Booth J, Sheaff M, Yaqoob M. Nephrotic syndrome in adults. Acute Med. 2018;17(1):36\u201343.","journal-title":"Acute Med"},{"issue":"6","key":"1632_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/pr.2015.38","volume":"77","author":"J Liu","year":"2015","unstructured":"Liu J, Gao X, Zhai Y, Shen Q, Sun L, Feng C, et al. A novel role of angiopoietin-like-3 associated with podocyte injury. PEDIATR RES. 2015;77(6):732\u20139.","journal-title":"PEDIATR RES"},{"issue":"6121","key":"1632_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science (New York, NY). 2013;339(6121):819\u201323.","journal-title":"Science (New York, N.Y.)."},{"issue":"6","key":"1632_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","volume":"13","author":"Y Wu","year":"2013","unstructured":"Wu Y, Liang D, Wang Y, Bai M, Tang W, Bao S, et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell. 2013;13(6):659\u201362.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1632_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1074\/jbc.M605024200","volume":"282","author":"SV Dandapani","year":"2007","unstructured":"Dandapani SV, Sugimoto H, Matthews BD, Kolb RJ, Sinha S, Gerszten RE, et al. Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem. 2007;282(1):467\u201377.","journal-title":"J Biol Chem"},{"issue":"5","key":"1632_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1097\/01.ASN.0000059864.88610.5E","volume":"14","author":"J Michaud","year":"2003","unstructured":"Michaud J, Lemieux LI, Dub\u00e9 M, Vanderhyden BC, Robertson SJ, Kennedy CRJ. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrology: JASN. 2003;14(5):1200\u201311.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"5","key":"1632_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0955-0674(03)00109-1","volume":"15","author":"KA DeMali","year":"2003","unstructured":"DeMali KA, Wennerberg K, Burridge K. Integrin signaling to the actin cytoskeleton. CURR OPIN CELL BIOL. 2003;15(5):572\u201382.","journal-title":"CURR OPIN CELL BIOL"},{"issue":"2","key":"1632_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12020-015-0838-9","volume":"52","author":"A Tikka","year":"2016","unstructured":"Tikka A, Jauhiainen M. The role of ANGPTL3 in controlling lipoprotein metabolism. Endocrine. 2016;52(2):187\u201393.","journal-title":"Endocrine"},{"issue":"2","key":"1632_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/ijms22020742","volume":"22","author":"S Bini","year":"2021","unstructured":"Bini S, D\u2019Erasmo L, Di Costanzo A, Minicocci I, Pecce V, Arca M. The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases? Int J Mol Sci. 2021;22(2):742.","journal-title":"Int J Mol Sci."},{"issue":"8","key":"1632_CR19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1194\/jlr.RA120000781","volume":"61","author":"YQ Chen","year":"2020","unstructured":"Chen YQ, Pottanat TG, Siegel RW, Ehsani M, Qian Y, Zhen EY, et al. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. J LIPID RES. 2020;61(8):1203\u201320.","journal-title":"J LIPID RES"},{"issue":"6","key":"1632_CR20","doi-asserted-by":"publisher","first-page":"E1249-58","DOI":"10.1073\/pnas.1717420115","volume":"115","author":"S Banfi","year":"2018","unstructured":"Banfi S, Gusarova V, Gromada J, Cohen JC, Hobbs HH. Increased thermogenesis by a noncanonical pathway in ANGPTL3\/8-deficient mice. P NATL ACAD SCI USA. 2018;115(6):E1249-58.","journal-title":"P NATL ACAD SCI USA"},{"key":"1632_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12882-015-0034-4","volume":"16","author":"R Dai","year":"2015","unstructured":"Dai R, Lin Y, Liu H, Rao J, Zhai Y, Zha X, et al. A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro. BMC NEPHROL. 2015;16:38.","journal-title":"BMC NEPHROL"},{"issue":"3","key":"1632_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2459\/JCM.0000000000001077","volume":"22","author":"A Cesaro","year":"2021","unstructured":"Cesaro A, Schiavo A, Moscarella E, Coletta S, Conte M, Gragnano F, et al. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies. J Cardiovasc Med (Hagerstown Md ). 2021;22(3):151\u201361.","journal-title":"J Cardiovasc Med (Hagerstown Md )"},{"issue":"4","key":"1632_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-019-02082-8","volume":"14","author":"F Gragnano","year":"2019","unstructured":"Gragnano F, Fimiani F, Di Maio M, Cesaro A, Limongelli G, Cattano D, et al. Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease. Intern Emerg Med. 2019;14(4):621\u20135.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"1632_CR24","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1038\/s41598-018-25237-7","volume":"8","author":"E Biterova","year":"2018","unstructured":"Biterova E, Esmaeeli M, Alanen HI, Saaranen M, Ruddock LW. Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease. Sci Rep. 2018;8(1):6752.","journal-title":"Sci Rep"},{"issue":"8","key":"1632_CR25","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1194\/jlr.M300091-JLR200","volume":"44","author":"MC Cheung","year":"2003","unstructured":"Cheung MC, Sibley SD, Palmer JP, Oram JF, Brunzell JD. Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II). J Lipid Res. 2003;44(8):1552\u20138.","journal-title":"J Lipid Res"},{"issue":"11","key":"1632_CR26","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00467-012-2376-5","volume":"28","author":"I Simic","year":"2013","unstructured":"Simic I, Tabatabaeifar M, Schaefer F. Animal models of nephrotic syndrome. Pediatr Nephrol. 2013;28(11):2079\u201388.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"1632_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12079-012-0184-0","volume":"7","author":"T Srivastava","year":"2013","unstructured":"Srivastava T, Sharma M, Yew K, Sharma R, Duncan RS, Saleem MA, et al. LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile. J CELL COMMUN SIGNAL. 2013;7(1):49\u201360.","journal-title":"J CELL COMMUN SIGNAL"},{"issue":"10","key":"1632_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Investig. 2004;113(10):1390\u20137.","journal-title":"J Clin Investig"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-022-01632-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T15:07:36Z","timestamp":1649603256000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-022-01632-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1186\/s12944-022-01632-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,10]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients and healthy controls agreed to participate in the study and signed informed consent forms. All experiments were performed in accordance with the Health Guide for the Care and Use of Laboratory Animals and were approved by the Biological Research Ethics Committee of Gansu Province People\u2019s Hospital (No. syll20130331).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}